Kosins A, Gao H, Blankenship R, Emmerson L, Ochoa J, Cook-Mills J
J Immunol. 2025; 214(2):199-210.
PMID: 40073242
PMC: 11879001.
DOI: 10.1093/jimmun/vkae041.
Meng J, Xiao H, Xu F, She X, Liu C, Canonica G
Immunol Res. 2025; 73(1):60.
PMID: 40069459
PMC: 11897119.
DOI: 10.1007/s12026-025-09606-9.
Zhao Y, Zhang L, Wu L, Duan X, Ji C, Xiao R
Dermatol Ther (Heidelb). 2025; .
PMID: 40057938
DOI: 10.1007/s13555-025-01368-4.
Parhizkar E, Vosough P, Baneshi M, Keshavarzi A, Lohrasbi P, Taghizadeh S
Arch Microbiol. 2025; 207(3):68.
PMID: 39988585
DOI: 10.1007/s00203-025-04267-6.
Tenenhaus M, Rennekampff H
Eur Burn J. 2025; 6(1).
PMID: 39982335
PMC: 11843913.
DOI: 10.3390/ebj6010002.
Type 2 immunity in allergic diseases.
Ogulur I, Mitamura Y, Yazici D, Pat Y, Ardicli S, Li M
Cell Mol Immunol. 2025; 22(3):211-242.
PMID: 39962262
PMC: 11868591.
DOI: 10.1038/s41423-025-01261-2.
The AhR-Ovol1-Id1 regulatory axis in keratinocytes promotes epidermal and immune homeostasis in atopic dermatitis-like skin inflammation.
Chen Z, Dragan M, Sun P, Haensel D, Vu R, Cui L
Cell Mol Immunol. 2025; 22(3):300-315.
PMID: 39939818
PMC: 11868582.
DOI: 10.1038/s41423-025-01264-z.
Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database.
Liu J, Desai K, Teng C, Sturm D, Stockbower G, Patadia H
Clinicoecon Outcomes Res. 2025; 17:69-77.
PMID: 39931253
PMC: 11809233.
DOI: 10.2147/CEOR.S506043.
Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review.
Torres T, Mendes-Bastos P, Cruz M, Duarte B, Filipe P, Lopes M
Dermatol Ther (Heidelb). 2025; 15(3):579-597.
PMID: 39930311
DOI: 10.1007/s13555-025-01352-y.
Topical Medications for Chronic Itch in Older Patients: Navigating a Pressing Need.
Bartley B, Pierce C, Hivnor C, Valdes-Rodriguez R
Drugs Aging. 2025; 42(3):213-233.
PMID: 39883297
DOI: 10.1007/s40266-024-01174-1.
NLRP3 deficiency aggravated DNFB-induced chronic itch by enhancing type 2 immunity IL-4/TSLP-TRPA1 axis in mice.
Huang S, Chen Z, Peng Z, Wang Y, Yang F, Tang Y
Front Immunol. 2025; 15:1450887.
PMID: 39867900
PMC: 11758165.
DOI: 10.3389/fimmu.2024.1450887.
Neurogenic inflammation and itch in barrier tissues.
Liu R, Buttaci D, Sokol C
Semin Immunol. 2025; 77:101928.
PMID: 39798211
PMC: 11893243.
DOI: 10.1016/j.smim.2024.101928.
Soothing the Itch: The Role of Medicinal Plants in Alleviating Pruritus in Palliative Care.
Goncalves S, Fernandes L, Caramelo A, Martins M, Rodrigues T, Matos R
Plants (Basel). 2025; 13(24.
PMID: 39771213
PMC: 11677410.
DOI: 10.3390/plants13243515.
A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2-11 Years with Moderate to Severe Atopic Dermatitis.
Gold L, Bissonnette R, Forman S, Zaenglein A, Kuo Y, Angel B
Am J Clin Dermatol. 2025; 26(2):275-289.
PMID: 39760983
PMC: 11850462.
DOI: 10.1007/s40257-024-00909-5.
Tumors in the setting of dupilumab use: A review of the literature.
Guo S, Wang L, Bu D, Liu F
World Allergy Organ J. 2025; 18(1):101006.
PMID: 39758935
PMC: 11697539.
DOI: 10.1016/j.waojou.2024.101006.
IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid.
Wang Y, Zhang X, Teng Y, Shen C
Front Immunol. 2024; 15:1499868.
PMID: 39735535
PMC: 11681427.
DOI: 10.3389/fimmu.2024.1499868.
Practical guide for the diagnosis and treatment of localized and generalized cutaneous pruritus (chronic itch with no underlying pruritic dermatosis).
Hashimoto T, Okuno S
J Dermatol. 2024; 52(2):204-220.
PMID: 39663861
PMC: 11807371.
DOI: 10.1111/1346-8138.17565.
From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL-33.
Obata-Ninomiya K, Jayaraman T, Ziegler S
Clin Transl Immunology. 2024; 13(12):e70020.
PMID: 39654685
PMC: 11626414.
DOI: 10.1002/cti2.70020.
Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis.
Lin J, Luo M, Zhuo Q, Chen N, Zhang H, Han Y
Front Pharmacol. 2024; 15:1429709.
PMID: 39629076
PMC: 11611541.
DOI: 10.3389/fphar.2024.1429709.
Mechanism of medical hemorrhoid gel in relieving pruritus ani via inhibiting the activation of JAK2/STAT3 pathway.
Ai Z, Yuan D, Cai J, Dong R, Liu W, Zhou D
Front Med (Lausanne). 2024; 11:1487531.
PMID: 39606625
PMC: 11600105.
DOI: 10.3389/fmed.2024.1487531.